Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Nov 20, 2015
Insider Transaction Report
Form 4
Miele Stanley G
SVP Sales & Marketing
Transactions
- Award
Common Stock, Class A (ESPP)
2015-06-30$13.37/sh+52$695→ 52 total - Award
Common Stock, Class A (ESPP)
2015-09-30$14.52/sh+41$595→ 93 total
Footnotes (4)
- [F1]The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period April 1, 2015 through June 30, 2015. This transaction is exempt under Rule 16(b)-3(c).
- [F2]In accordance with the ESPP, these shares were purchased at 85% of the closing price of the issuer's common stock on April 1, 2015.
- [F3]The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's ESPP for the period July 1, 2015 through September 30, 2015. This transaction is exempt under Rule 16(b)-3(c).
- [F4]In accordance with the ESPP, these shares were purchased at 85% of the closing price of the issuer's common stock on July 1, 2015.